Anastasia Bortz
Family · Nazareth, PANPI 1740751155
Payments from drug & device makers
Across 43 payments — averaging $171.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$6K
- AstraZeneca$567
- Genmab U.S., Inc.$387
- Johnson & Johnson$243
- Tactile Systems Technology Inc$177
- Immunogen, Inc.$95
- plus $306 from 6 others
What the payments were for
- Speaking & faculty fees$4,91467%
- Food & beverage$2,44633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 14 | $5,586 |
| AstraZeneca | 7 | $567 |
| Genmab U.S., Inc. | 5 | $387 |
| Johnson & Johnson | 3 | $243 |
| Tactile Systems Technology Inc | 2 | $177 |
| Immunogen, Inc. | 1 | $95 |
| Caris MPI, Inc. | 1 | $90 |
| Myriad Genetic Laboratories, Inc. | 2 | $74 |
| Merck | 4 | $73 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Myovant Sciences Inc. | 1 | $21 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,360 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $1,205 |
| Nystatin | 23 | $257 |
| Clobetasol Propionate | 12 | $225 |
| Gabapentin | 27 | $222 |
| Levothyroxine Sodium | 13 | $100 |
Paid to pharmacies, not to this prescriber.
Other family in Nazareth
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.